Title:
METHOD OF TREATING CANCER USING PLATELET RELEASATE
Document Type and Number:
WIPO Patent Application WO2005065242
Kind Code:
A3
Abstract:
Platelets are concentrated from the blood of a patient. The platelets are treated by a method such as ultrasound or agitation to obtain platelet releasate. The releasate as a whole or a component thereof is formulated into an injectable formulation which is administered to the same patient the platelets were extracted from in order to treat the patient's cancer.
Inventors:
MISHRA ALLAN (US)
Application Number:
PCT/US2004/043088
Publication Date:
June 22, 2006
Filing Date:
December 23, 2004
Export Citation:
Assignee:
AM BIOSOLUTIONS (US)
MISHRA ALLAN (US)
MISHRA ALLAN (US)
International Classes:
A61K38/00; A61K35/14; A61K35/15; A61K35/16; A61K35/19; A61K35/28; C12N5/00; C12N5/078; A61K35/12
Foreign References:
| US20040126885A1 | 2004-07-01 | |||
| US5599558A | 1997-02-04 | |||
| US6214338B1 | 2001-04-10 | |||
| US20030152639A1 | 2003-08-14 | |||
| US5834418A | 1998-11-10 |
Other References:
MARTINEZ-GONZALEZ ET AL.: "Do ambulatory-use Platelet-Rich Plasma (PRP) concentrates present risks?", MEDICINA ORAL, vol. 7, 2002, pages 375 - 390, XP002998091
Download PDF:
Previous Patent: SMMR (SMALL MOLECULE METABOLITE REPORTERS) FOR USE AS IN VIVO GLUCOSE BIOSENSORS
Next Patent: HYBRID CUBIC/HEXAGONAL DIAMONDOIDS
Next Patent: HYBRID CUBIC/HEXAGONAL DIAMONDOIDS